Clinical Trial Update: Efficacy and Safety of XEN63 Gel Implant

View source ↗

Summary

Clinical trial update indicates the XEN63 Gel Implant for glaucoma is currently enrolling by invitation, sponsored by Mario Stirpe.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Glaucoma

Drugs mentioned

• XEN63 Gel Implant

Snippet

Sponsor: Mario Stirpe | Conditions: Glaucoma | Status: ENROLLING_BY_INVITATION